Journal
BMC PEDIATRICS
Volume 21, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12887-021-02618-y
Keywords
COVID-19; Vaccination; Newborn; Cord blood; Maternal
Categories
Ask authors/readers for more resources
This is the first known case of an infant with detectable SARS-CoV-2 IgG antibodies in cord blood after maternal vaccination.
BackgroundMaternal vaccination for Influenza and Tetanus, Diphtheria, acellular Pertussis (TDaP) have been well studied in terms of safety and efficacy for protection of the newborn by placental passage of antibodies. Similar newborn protection would be expected after maternal vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19). There is a significant and urgent need for research regarding safety and efficacy of vaccination against SARS-CoV-2 during pregnancy.Case presentationA vigorous, healthy, full-term female was born to a COVID-19 naive mother who had received a single dose of messenger RNA (mRNA) vaccine for SARS-CoV-2 3 weeks prior to delivery. IgG cord blood antibodies were detected to SARS-CoV-2 at the time of birth.ConclusionHere, we report the first known case of an infant with SARS-CoV-2 IgG antibodies detectable in cord blood after maternal vaccination.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available